NDP 2022 Red Lion incident: Safety review finds 'no procedural lapses', larger landing zones to be put further from spectators

-
May 8 Parliament sitting: High COE prices among questions filed, ministerial statement on 'meeting transport needs of S'poreans' (2164811)

Entradas populares de este blog

Breaking news: F.D.A. approves weight loss drug to treat obstructive sleep apnea

-
Imagen
Zepbound is the first prescription drug approved specifically to treat the common condition. View in browser Dec. 20, 2024, 5:22 p.m. ET BREAKING NEWS Dustin Chambers for The New York Times F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder. Read more Need help? Review our newsletter help page or contact us for assistance. You received this email because you signed up for Breaking News from The New York Times. To stop receiving Breaking News, unsubscribe . To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings . To opt out of updates and offers sent from The Athletic, submit a request . Subscribe to The Times Get The New York Times app Connect with us on: Change Your Email Privacy Policy Contact Us Califo...
Leer más

Breaking news: U.S. job growth ends 2024 strong

-
Imagen
Employers added 256,000 jobs in December, a stronger-than-expected result at the end of the year. View in browser Jan. 10, 2025, 8:59 a.m. ET BREAKING NEWS Karl Russell U.S. Job Growth Ends the Year Strong Employers added 256,000 jobs in December. The stronger-than-expected result sent stocks downward on the prospect of a hotter economy delaying or halting rate cuts. Follow live updates Sign up for the the DealBook newsletter. Our columnist Andrew Ross Sorkin and his Times colleagues help you make sense of major business and policy headlines — and the power-brokers who shape them. Get it in your inbox Need help? Review our newsletter help page or contact us for assistance. You received this email because you signed up for Breaking News from The New York Times. To stop receiving Breaking News, unsubscribe . To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings . To opt out of updates and offers sent from The Athleti...
Leer más

Dozens in their town developed a mysterious brain disease. No one knows why.

-
Imagen
The scientific puzzle has now become a political maelstrom. View in browser | nytimes.com August 19, 2024 Doctors identified a cluster of patients in the Canadian province of New Brunswick with similar brain diseases. Laurie Beatty is one of many local residents who have exhibited comparable, inexplicable symptoms of neurological decline. Brendan George Ko for The New York Times In the absence of answers, a political maelstrom has ensued. → Sign up for The New York Times Magazine newsletter. Get the best of each issue with cover stories, long reads and columns like Talk, Diagnosis and Eat. Get it in your inbox Need help? Review our newsletter help page or contact us for assistance. You received this message because you signed up for updates from The New York Times. To stop receiving From The Times, unsubscribe . To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings . To opt out of updates and offers sent from The ...
Leer más